Technorati Authority:
420
Recent blog post
-
ImmunoGen Signs 2nd Licensing Deal with Amgen
ImmunoGen has licensed its anti-cancer technology to Amgen for an upfront payment of $1 million. The deal gives biotechnology company Amgen the right to use ImmunoGen’s maytansinoid targeted antibody payload (TAP) technology to create cancer-fighting ther...
19 hours ago
